主动脉瓣置换术老年患者的衰弱评估:FRAILTY-AVR研究
该前瞻性队列研究在3国14中心纳入1020例接受TAVR或SAVR的老年患者,比较7种衰弱量表对术后1年死亡和残疾的预测价值。结果显示EFT量表预测1年死亡最强(调整OR 3.72,95%CI 2.54-5.45),并推荐使用包含下肢无力、认知障碍、贫血和低白蛋白血症的4项简表。
要点
- 衰弱是TAVR或SAVR术后死亡和残疾的风险因素。
- EFT量表对1年死亡的预测最强,C统计量提升0.071。
- 推荐使用4项EFT量表评估该人群衰弱。
核心结论
- 衰弱是TAVR或SAVR术后死亡和残疾的风险因素。
- 包含下肢无力、认知障碍、贫血和低白蛋白血症的4项EFT量表优于其他衰弱量表,推荐用于该临床情境。
研究设计与样本
- 前瞻性队列研究,2012至2016年从3国14中心纳入1020例接受TAVR或SAVR的老年患者,中位年龄82岁。
- 比较7种衰弱量表:Fried、Fried+、Rockwood、Short Physical Performance Battery、Bern、Columbia和EFT。
主要发现
- 根据不同量表,衰弱患病率为26%至68%。
- EFT测量的衰弱是1年死亡最强预测因子(调整OR 3.72;95%CI 2.54至5.45),C统计量提升0.071(p<0.001),综合判别改善0.067(p<0.001)。
- EFT也是1年残疾加重(调整OR 2.13;95%CI 1.57至2.87)和30天死亡(调整OR 3.29;95%CI 1.73至6.26)的最强预测因子。
关键数值与推荐
- EFT量表包含4项:下肢无力、认知障碍、贫血和低白蛋白血症。
- EFT预测1年死亡的调整OR为3.72(95%CI 2.54至5.45),C统计量提升0.071(p<0.001)。
临床怎么用
- 在TAVR或SAVR术前使用EFT量表评估衰弱,以识别术后死亡和残疾高风险患者。
- EFT量表简洁(4项),便于临床常规应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frailty is a geriatric syndrome that diminishes the potential for functional recovery after a transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) procedure; however, its integration in clinical practice has been limited by a lack of consensus on how to measure it. OBJECTIVES: This study sought to compare the incremental predictive value of 7 different frailty scales to predict poor outcomes following TAVR or SAVR. METHODS: A prospective cohort of older adults undergoing TAVR or SAVR was assembled at 14 centers in 3 countries from 2012 to 2016. The following frailty scales were compared: Fried, Fried+, Rockwood, Short Physical Performance Battery, Bern, Columbia, and the Essential Frailty Toolset (EFT). Outcomes of interest were all-cause mortality and disability 1 year after the procedure. RESULTS: The cohort was composed of 1,020 patients with a median age of 82 years. Depending on the scale used, the prevalence of frailty ranged from 26% to 68%. Frailty as measured by the EFT was the strongest predictor of death at 1 year (adjusted odds ratio [OR]: 3.72; 95% confidence interval [CI]: 2.54 to 5.45) with a C-statistic improvement of 0.071 (p < 0.001) and integrated discrimination improvement of 0.067 (p < 0.001). Moreover, the EFT was the strongest predictor of worsening disability at 1 year (adjusted OR: 2.13; 95% CI: 1.57 to 2.87) and death at 30 days (adjusted OR: 3.29; 95% CI: 1.73 to 6.26). CONCLUSIONS: Frailty is a risk factor for death and disability following TAVR and SAVR. A brief 4-item scale encompassing lower-extremity weakness, cognitive impairment, anemia, and hypoalbuminemia outperformed other frailty scales and is recommended for use in this setting. (Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions; NCT01845207).
引用
- Afilalo J, Lauck S, Kim DH, et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. J Am Coll Cardiol. 2017. PMID: 28693934. doi:10.1016/j.jacc.2017.06.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。